Q4 2025 earnings call: 15% revenue growth, $3.9M sales, CapsoCam Colon Gen 2/AI 510(k) timing, trials & funding—read now.
CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results for the fourth ...
Tech Xplore on MSN
Smart yarn tracks muscle activity in the body
Created from noise-resistant, conductive threads, a high-tech new smart fabric could find uses in health monitoring, sports ...
An international research team has reported an artificial nociceptor system that captures the temperature-dependent threshold ...
This article provides a blueprint for Brigade Combat Teams (BCTs) to improve their Air Defense Artillery (ADA) planning and execution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results